Oxford University/AstraZeneca Covid-19 vaccine approved

first_imgOxford University/AstraZeneca Covid-19 vaccine approved The COVID-19 vaccine developed by Oxford University/AstraZeneca has today been given regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA) after meeting required safety, quality and effectiveness standards.Following a rigorous, detailed scientific review by the MHRA’s expert scientists and clinicians and on the basis of the advice of its scientific, independent advisory body, the Commission on Human Medicines, the UK regulator has approved COVID-19 Vaccine AstraZeneca for use across the UK.MHRA Chief Executive Dr June Raine said:We are delighted to announce the good news that the Oxford University/AstraZeneca vaccine for COVID-19 is now approved for supply following a robust and thorough assessment of all the available data.A huge collaborative effort and commitment goes into these assessments which include reviewing vast amounts of data. Our staff have worked tirelessly to ensure we continue to make safe vaccines available to people across the UK.No stone is left unturned when it comes to our assessments. This approval means more people can be protected against this virus and will help save lives. This is another significant milestone in the fight against this virus. We will continue to support and work across the healthcare system to ensure that COVID-19 vaccines are rolled out safely across the UK. Protecting health and improving lives is our mission and what we strive for.The Oxford University/AstraZeneca vaccine has been approved for use for people 18 years or older and consists of two doses, with the second dose administered 4-12 weeks after the first dose. The transportation and storage requirements for this vaccine mean that it needs to be kept at temperatures of 2C to 8C, which is similar to a conventional fridge for up to six months and can be administered within existing healthcare settings.Oxford University/AstraZeneca has been submitting data to the MHRA since September 2020 under the rolling review process, enabling data to be reviewed in stages, as it became available.The National Institute for Biological Standards and Control , part of the MHRA, has been and will continue doing, independent laboratory testing to ensure that every batch of the vaccine meets the expected standards of safety and quality.As with any vaccine or medicine, COVID-19 vaccines require continuous safety monitoring by the MHRA and that the benefits in protecting people against COVID-19 must be greater than any side-effect or potential risks.Additional updates relating to use of the Pfizer/BioNTech vaccineThe Commission on Human Medicines (CHM) has also reviewed further data for the Pfizer BioNTech vaccine as it has become available and has recommended the following changes:Pregnancy and women who are breastfeeding – the vaccine should only be considered for use in pregnancy when the potential benefits outweigh any potential risks for the mother and baby. Women should discuss the benefits and risks of having the vaccine with their healthcare professional and reach a joint decision based on individual circumstances. Women who are breastfeeding can also be given the vaccine. This advice is in line with pregnancy and breastfeeding advice for the Oxford University/AstraZeneca vaccineAllergies – anyone with a previous history of allergic reactions to the ingredients of the vaccine should not receive it, but those with any other allergies such as a food allergy can now have the vaccine.Dosage interval – the advice has been updated to say that the second dose of the Pfizer/BioNTech vaccine should be given at least 21 days after the first dose.NotesThe Medicines and Healthcare products Regulatory Agencyis responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe. All our work is underpinned by robust and fact-based judgements to ensure that the benefits justify any risks.The decision to approve the supply of this vaccine was taken under Regulation 174 of the Human Medicine Regulations 2012, which enables rapid temporary regulatory approvals to address significant public health issues such as a pandemic.The Medicines and Healthcare products Regulatory Agency (‘the agency’) has three centres. The MHRA, the National Institute for Biological Standards and Control (NIBSC) and the Clinical Practice Research Datalink (CPRD). The agency is an executive agency of the Department of Health and Social Care.The Commission on Human Medicines (CHM) advises ministers and the MHRA on the safety, efficacy and quality of medicinal products. The CHM is an advisory non-departmental public body, sponsored by the Department of Health and Social Care. /Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here. Why?Well, unlike many news organisations, we have no sponsors, no corporate or ideological interests. We don’t put up a paywall – we believe in free access to information of public interest. Media ownership in Australia is one of the most concentrated in the world (Learn more). Since the trend of consolidation is and has historically been upward, fewer and fewer individuals or organizations control increasing shares of the mass media in our country. According to independent assessment, about 98% of the media sector is held by three conglomerates. This tendency is not only totally unacceptable, but also to a degree frightening). Learn more hereWe endeavour to provide the community with real-time access to true unfiltered news firsthand from primary sources. It is a bumpy road with all sorties of difficulties. We can only achieve this goal together. Our website is open to any citizen journalists and organizations who want to contribute, publish high-quality insights or send media releases to improve public access to impartial information. You and we have the right to know, learn, read, hear what and how we deem appropriate.Your support is greatly appreciated. All donations are kept completely private and confidential.Thank you in advance!Tags:biological, breastfeeding, Commission, covid-19, Department of Health, Government, healthcare, medical devices, medicine, pregnancy, public health, quality, regulation, research, Scientists, UK, UK Governmentlast_img read more

Registration for GOJ Health Card Begins Monday

first_imgRelatedHouse Approves Amendments to Smoking Regulations Registration for GOJ Health Card Begins Monday Health & WellnessFebruary 3, 2014Written by: Bryan Miller Come Monday, February 3, registration will get underway for the Government of Jamaica (GOJ) Health Card.The card, which is available to all Jamaicans, will be the primary means by which citizens can access health services, including pharmaceuticals, in the public sector. Persons will be able to use the card to access drugs at public pharmacies and Drug Servs as of March 3.Speaking at a press briefing held on January 31 at the Montego Bay Convention Centre in St. James, Minister of Health, Hon. Dr. Fenton Ferguson, said that registration forms have been provided to all the Regional Health Authorities (RHAs) for distribution to their respective facilities.Registration will also be facilitated at the Ministry of Health’s head office and the National Health Fund (NHF).Minister Ferguson said it will take three weeks after submitting a completed registration form for persons to receive their GOJ Health Card.The NHF will be in charge of processing applications, printing and mailing the cards.  “Persons, who already have an NHF card, will not be required to apply for the GOJ Health Card, as they can simply use their NHF card in lieu of the GOJ card,” Dr. Ferguson advised.The GOJ Health card is being implemented at a cost of $85 million, with an annual maintenance cost of approximately $22 million.The Health Minister said that every citizen of Jamaica is expected be registered and issued with a card overtime.A full public education programme on the benefits of the card and the registration process will get underway immediately in the print and electronic media.The card will give patrons of public health facilities ease of access to medications on the Vital Essential and Necessary (VEN) drug list at no cost.It will also improve the mechanism to bill private health insurance providers, as it will state whether or not the individual has health insurance. RelatedRegistration for GOJ Health Card Begins Monday FacebookTwitterWhatsAppEmail Advertisementscenter_img Story HighlightsThe card, which is available to all Jamaicans, will be the primary means by which citizens can access health services, including pharmaceuticals, in the public sector. Persons will be able to use the card to access drugs at public pharmacies and Drug Servs as of March 3. Registration forms have been provided to all the Regional Health Authorities (RHAs) for distribution to their respective facilities. RelatedOver $28 Billion Disbursed Under NHF Photo: JIS PhotographerMinister of Health, Hon. Dr. Fenton Ferguson (2nd left), provides details about the Government of Jamaica (GOJ) Health Card, at a press briefing held on January 31 at the Montego Bay Convention Centre in St. James. Others (from left) are: Chief Medical Officer in the Ministry, Dr. Kevin Harvey; Permanent Secretary, Dr. Jean Dixon; and Chief Executive Officer of the National Health Fund (NHF), Everton Anderson. Registration for GOJ Health Card Begins MondayJIS News | Presented by: PausePlay% buffered00:0000:00UnmuteMuteDisable captionsEnable captionsSettingsCaptionsDisabledQualityundefinedSpeedNormalCaptionsGo back to previous menuQualityGo back to previous menuSpeedGo back to previous menu0.5×0.75×Normal1.25×1.5×1.75×2×Exit fullscreenEnter fullscreenPlaylast_img read more

Hurricane Dorian: EU €500,000 initial emergency aid to Bahamas

first_img Share this:PrintTwitterFacebookLinkedInLike this:Like Loading… You may be interested in… (Bridgetown, 9 September 2019) The EU is mobilising an initial 500,000 euro in immediate emergency funding to assist those in the Bahamas affected by the category 5 Hurricane Dorian, which devastated the Bahamas on 2 September. Oct 16, 2020 Bahamians assessing the damage from Hurricane Isaias The Bahamas bracing for hurricane conditions today Jul 31, 2020 CARPHA Partners with, PAHO to Ensure Caribbean States’… PM Minnis urges ACP countries to intensify response to climate emergency(Bahamas Information Service) , BRUSSELS, Belgium – Vulnerable areas in the Africa Caribbean and Pacific (ACP) Group of States must collectively and urgently intensify its response to the climate emergency Prime Minister the Most Hon. Dr. Hubert Minnis told ACP Ambassadors today. The Prime Minister made the plea while addressing…November 15, 2019In “Agriculture”CARICOM reacts as ‘Dorian’ pounds BahamasChairman of the Caribbean Community (CARICOM), Prime Minister Allen Chastanet of Saint Lucia was among the regional leaders who expressed concern and support  to The Bahamas, devastated by category five hurricane Dorian which struck on Sunday 1 September. It left extensive damage across the islands of Abaco and is currently pounding Grand…September 2, 2019In “Featured”CARPHA Deploys Technical Staff to the Bahamas Ahead of Hurricane DorianPort of Spain, Trinidad and Tobago.  On Friday, August 30, 2019, the Caribbean Public Health Agency (CARPHA), as part of the Regional Response Mechanism (RRM) led by the Caribbean Disaster Emergency Management Agency Coordinating Unit (CDEMA), propositioned a member of staff to support the Government of the Bahamas in rapidly…September 2, 2019In “CARICOM”Share this on WhatsApp Statement by The Bahamas Prime Minister on Preparations for… The funding will address urgent needs such as shelter, water, hygiene and food. The European Union’s 24/7 Emergency Response Coordination Centre is in close contact with the authorities of the Bahamas to monitor the situation and channel further EU assistance. In addition, the Commission has deployed a Humanitarian Expert to conduct a rapid needs assessment and the EU’s emergency Copernicus satellite service is currently providing maps of the area. “Hurricane Dorian has left a large trail of destruction with many casualties and leaving homes in ruins. We will do all we can to help, getting aid in to the people on the ground. Our thoughts are with all those affected by this tragedy and with the Bahamian authorities and brave first responders on the scene. The EU stands ready to provide further assistance,” said Christos Stylianides, Commissioner for Humanitarian Aid and Crisis Management. Offers have also been received from EU Member States to assist with the recovery. France – 30 tonnes of humanitarian material, Luxembourg – satellite communication platform, which can provide data and voice communication to field emergency centre, Belgium – vessel with water purification system, The Netherlands – two navy vessels from St. Martin carrying humanitarian cargo, including two helicopters and rubber boats. Aug 1, 2020 Aug 2, 2020last_img read more